<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03474731</url>
  </required_header>
  <id_info>
    <org_study_id>14-0314-P6H</org_study_id>
    <nct_id>NCT03474731</nct_id>
  </id_info>
  <brief_title>Clinic to Community Navigation to Improve Diabetes Outcomes</brief_title>
  <acronym>CCN</acronym>
  <official_title>Clinic to Community Navigation to Improve Diabetes Outcomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nancy Schoenberg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Kentucky</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background and justification: Nearly 29 million Americans (9.3% of the population) have type
      2 Diabetes Mellitus (T2DM) and another 86 million are considered prediabetic, 20-30% of whom
      will develop diabetes within five years.4,5 T2DM disproportionately affects those from lower
      socioeconomic status (SES) and rural backgrounds. Appalachian residents represent an extreme
      version of this already vulnerable population, with rates of diabetes 46% higher than
      national averages.6,7 The investigators have developed, pilot tested (N=41) and refined (N=48
      in-depth interviews, 4 focus groups with 31 participants, and 2 CAB meetings with 16
      members), a culturally appropriate, feasible, and promising intervention that combines
      diabetes self-management education and tailored patient navigation intervention., Goal: Our
      goal focuses on reducing HbA1c, BMI, blood pressure, lipids, and waist circumference and
      improving T2DM self-management and clinic attendance. Leveraging local assets, including
      faith communities, local health facilities, trained community health workers, and social
      support, the investigators will expand a promising and refined pilot study and assess
      outcomes, satisfaction and cost effectiveness. Innovation and impact: The proposed project is
      among the first RCT to combine the two most influential approaches to diabetes control--
      self-management education and tailored patient navigation in a community setting. The
      Community to Clinic Navigation (CCN) intervention has the potential to sustainably empower
      hard to reach populations with effective self-management education and enhance the quality of
      healthcare in traditionally underserved communities, greatly improving T2DM outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Background: Appalachian residents maintain disproportionately high rates of Type 2
           Diabetes Mellitus (T2DM) and suffer tremendous burdens from diabetic complications. The
           main challenges to stemming adverse outcomes from T2DM involve ensuring optimal clinical
           care and self-management. Because the prevalence of diabetes has tripled since 2005, the
           already low supply of primary care physicians combined with this tremendous chronic
           disease burden places huge demands on providers in rural Appalachia. Enhancing the
           quality and efficiency of these practices by linking to community health workers has the
           potential of mitigating the adverse effects of these shortages.

           Patient navigation, particularly a clinic to community navigation (CCN) model offers an
           innovative approach to address these inequities. Patient navigation has been implemented
           almost exclusively in the cancer setting, despite being promising for chronic disease
           management. The proposed project is, to our knowledge, the first to test a hybrid model
           of clinic (health promotion professional) plus community (community health worker)
           navigation among rural residents. Clinical patient navigation has been shown to
           facilitate appointment setting and return visits, may improve goal setting, and enhances
           some adherence (medication taking, blood glucose testing), but does not address some key
           psychosocial (self-efficacy, patient activation) and practical concerns (transportation,
           childcare, self-management) challenges. Community-based navigation programs have been
           shown to enhance self-efficacy, decrease community barriers to care (e.g.,
           transportation), and improved self-management, but may be less effective in ensuring
           return visits and working collaboratively with the doctor.

        2. Objectives: The investigators aim to test a CCN program that may improve the most
           salient influences on diabetes outcomes and self-management, the health care context and
           the patient's home context. Specifically, the investigators will (1) recruit 1200
           participants from community settings with T2DM and HbA1c levels between 9-11% and
           randomize them to one of three arms, DSMP; PN, or combined CCN intervention; (2) the
           investigators will administer three quantitative assessments. All activities will take
           place in Appalachia. Outcomes include physiologic data (HbA1C levels, blood pressure,
           lipids, waist circumference and BMI, obtained by research staff); quantitative data
           collection of self-management (medication taking, blood glucose, appointment adherence,
           diet, physical activity, foot and eye care, obtained by interviewer); and psychosocial
           variables (self-efficacy, patient activation, obtained by interviewer).

        3. Study Design: Behavioral randomized controlled trial, single blind design.

        4. Study Population: Eligibility criteria: Adults 18+; Appalachian residence, and HBA1c
           levels between 9-11%. Those who do not meet these inclusion criteria, are cognitively
           impaired, or who do not wish to participate will be excluded. All race/ethnicities and
           both genders will be included. Participants will be enrolled on a rolling basis from
           June 1, 2014-June 2, 2019. Participants will be involved in the study for approximately
           one year. The investigators anticipate a total of 1200 participants.

        5. Subject Recruitment Methods and Privacy: Participants will be recruited through churches
           and other community settings. If eligible (see above), project staff will call potential
           participants within five days to verify eligibility and determine their interest in
           participating in the study.

        6. Informed Consent Process: For those indicating an interest in participating, staff will
           visit potential participants at their home or a location of their choosing and
           administer the informed consent document. Study personnel for all phases of the project
           will provide a clear explanation of the project and invite questions. Our informed
           consent forms are written in a basic language. Interested participants will be asked to
           provide their signature on the informed consent forms. A copy of the signed consent will
           be provided for all participants. All forms will be read to participants to allay
           concerns about limited literacy. No non-English speaking or cognitively impaired
           participants will be recruited.

        7. Research Procedures: The consort diagram (Figure 1) below provides an estimation and
           visual description of the recruitment and sampling frame.

           Fig 1: Consort diagram of enrollment

             1. Once informed consent documents are completed, participants (N=1200) will undergo
                the baseline assessment. Baseline, posttest, and exit assessments will consist of
                the same measures highlighted in Table 3.

             2. There will be three arms. For those randomized to the diabetes self management
                program (n=435), within two weeks of initial recruitment and baseline assessment,
                project staff will schedule the participant to attend a group Diabetes
                Self-management Program, a six week, lay lead and en evidence-based diabetes home
                self-management program (See Table 1, DSMP contents). Staff will arrange for the
                group sessions of the DSMP. One session will take place every other week. Upon
                completion of the DSMP program, approximately three month later, clinic navigation
                will be implemented. For those randomized to the Patient Navigation group, within
                two weeks of initial recruitment and baseline assessment, project staff will
                schedule the participant to meet with the Community Health Worker who will
                strategize about insuring that patients make their doctors' appointments as
                scheduled. The CHW/Patient Navigator will make at least 4 calls to each participant
                randomized to this group. For those randomized to the combined Community to Clinic
                Navigation, CCN (n=435), both of the activities for the Diabetes self management
                education group and the Patient navigation will be conducted. At month 5-6, the
                posttest will take place. To assess sustainability, 3-4 months later, navigation
                again will take place. An interviewer will complete the exit interview in month
                10-11 using the same assessments. All throughout the intervention, standard medical
                visits will take place.

           Fig 2: Flow diagram of intervention and control activities by month

           Table 1: DSMP contents and conduct:

           Class Number Content/Objectives./Activities 1 Diabetes: causes, diagnosis, incidence,
           and prevalence Discussion using a pancreas model and the handout &quot;Understanding
           Diabetes&quot;. How to talk with your doctor and being a proactive patient. Goal setting 2
           Blood glucose testing, hyperglycemia, and hypoglycemia Discussion of the blood
           glucose-testing procedure, review of the handouts &quot;Hyperglycemia&quot; and &quot;Hypoglycemia.
           Goal check in 3 Eating right for diabetes, discussion of the food pyramid and dietary
           strategies ; Review of handouts. Goal check in 4 Avoiding complications: Eye care,
           dental care, neuropathy, hypertension Discussion of appropriate eye care, dental care,
           kidney care. Review of how to talk with your doctor. Goal check in 5 Getting active:
           review of physical activity and foot care. Goal check in 6 Empowerment and goal check
           in. Class discussion.

           Table 2: Timeline

           Activity Q1 Q2 Q3 Q4 Staff training Recruitment, informed consent, enrollment,
           randomization Baseline medical record review/ interview 0 CCN arm participants receive
           DSM sessions (6 sessions total) and navigation to clinic X X Posttest 1 0 CCN arm
           Navigation X Exit interview 0 CCN= clinic to community navigation (intervention arm);
           DSM= diabetes self-management; X= intervention activity; 0= assessment

        8. Resources: The research and intervention activities will be conducted in participants'
           homes, community sites, and the health clinics.

        9. Potential Risks: The potential risks from participating in the study are very small.
           Some risk of pain from a finger prick or psychological upset could result from
           responding to interview questions or the emotional distress from questions about
           diabetes management. The most significant risk involves any threat to confidentiality.
           However, all project staff will be human subjects trained and have extensive experience
           maintaining participant confidentiality.

       10. Safety Precautions: In each stage of the research, the investigators will make every
           effort to provide protection against risks. Study personnel will provide a clear
           explanation of the project and invite questions during enrollment. In the rare event
           that a participant experiences psychological distress resulting from the interview
           questions or from the intervention, our staff will contact Dr. Van Breeding, internal
           medicine physician at the MCHC. Dr. Breeding will consult with the participant, debrief
           and discuss the participant's concerns, and refer participants to any additional
           support. In addition, all project staff will receive training on how to respond to a
           participant who needs additional assistance with diabetes management.

       11. Benefit vs. Risk Participation in the study involves little risk for subjects in
           comparison to the potential benefits of adopting improving diabetes outcomes.
           Participants in the intervention group will receive their usual care, plus navigation
           from a staff person at MCHC and an evidence-based diabetes self-management program at no
           cost. If they are not assigned to the intervention arm, they will receive their usual
           diabetes care. Given the disproportionate diabetes burden experienced by Appalachian
           populations, implementing and evaluating this novel, theory based intervention has the
           potential to save many lives while advancing intervention science.

       12. Available Alternative Treatment(s): Participants will be randomized to the intervention
           (the standard of care plus navigation with a clinic employee and community-based
           navigation) OR will receive the standard treatment, which involves brief
           clinically-based consultation with the health care provider.

       13. Research Materials, Records, and Privacy: Two sources of data will be collected:
           physiologic data collection (HbA1C levels, blood pressure, lipids, and BMI); and
           quantitative assessments (surveys). Table 3 highlights the specific data to be
           collected.

           Table 3: Variables Data sources and collector Main outcomes HbA1C, blood pressure,
           lipids, waist circumference, BMI Additional outcomes: Self-management outcomes
           Medication taking, blood glucose testing, appointment adherence, diet, physical
           activity, foot and eye care.

           Assessments by UK project staff Diabetes Empowerment Scale (self-efficacy), patient
           activation Assessments by UK project staff Sociodemographic, self-perceived health
           status, depression, Clinic attendance, assessments by UK project staff

       14. Confidentiality Confidentiality of all data will be maintained by never linking paper or
           computer copy of data with the participants' names. A sheet with the participant's name,
           address, telephone number, and identification number will be kept by the Project
           Director and Principal Investigator separately in a locked file. Only staff members who
           are authorized to review files will be permitted access to the data. As part of our
           training, each lay health adviser and interviewer will be asked to sign a
           confidentiality pledge promising never to reveal, alter, or falsify survey data. This
           pledge is especially important in small, tight-knit rural communities. Data are held in
           password-protected computers and secure servers at University of Kentucky which have
           extensive firewalls and security measures. The investigator will keep all records
           (tapes, informed consent documents, and other records like completed questionnaires) for
           a minimum of six years after the completion of the study.

      16. Costs to Subjects: N/A for program participation. Some costs associated with
      transportation may occur.

      17. Data and Safety Monitoring: N/A 18. Subject Complaints: Participants will be asked to
      contact the investigator, Dr. Nancy Schoenberg at 859-323-8175 should they have any
      complaints. If they have any questions about their rights as a volunteer in this research,
      they will be asked to contact the staff in the Office of Research Integrity at the University
      of Kentucky at 859-257-9428 or toll free at 1-866-400-9428.

      19. Research Involving Non-English Speaking Subjects or Subjects from a Foreign Culture: N/A
      20. HIV/AIDS Research: N/A 20. PI-Sponsored FDA-Regulated Research: N/A
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">November 2024</completion_date>
  <primary_completion_date type="Anticipated">November 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Background and justification: Nearly 29 million Americans (9.3% of the population) have type 2 Diabetes Mellitus (T2DM) and another 86 million are considered prediabetic, 20-30% of whom will develop diabetes within five years.4,5 T2DM disproportionately affects those from lower socioeconomic status (SES) and rural backgrounds. Appalachian residents represent an extreme version of this already vulnerable population, with rates of diabetes 46% higher than national averages.6,7 We have developed, pilot tested (N=41) and refined (N=48 in-depth interviews, 4 focus groups with 31 participants, and 2 CAB meetings with 16 members), a culturally appropriate, feasible, and promising intervention that combines diabetes self-management education and tailored patient navigation intervention.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Hemoglobin A1c</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>Changes in hemoglobin A1c (HbA1c) will be measured with a Bayer DCA 2000+ Analyzer (21), which has a test coefficient of variation &lt; 5% consistent with requirements of the National Diabetes Data Group.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Body mass index</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>Change in calculated as a change in weight in kilograms divided by the square of height in meter.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Waist circumference</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>Change in Waist circumference at the umbilical waist using the Tech-Med model cat. no. 4414.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinic attendance</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>Data will be collected from clinic staff regarding participant clinic visit attendance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Health related quality of life survey (HRQOL)</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>Changes in sociodemographics, health status and behavior, self-perceived health status, function, depression, diabetes empowerment scale, patient activation, T2DM self-management knowledge, health-related quality of life will be assessed and reported as a single HRQOL score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic blood pressure</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>Change in systolic blood pressure will be reported as the average of two sphygmomanometer readings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic blood pressure</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>Change in diastolic blood pressure will be reported as the average of two sphygmomanometer readings</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>High density lipoprotein (HDL)</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>blood will be drawn and HDL will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in HDL over 18 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Low density lipoprotein (LDL)</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>blood will be drawn and LDL will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in LDL over 18 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cholesterol</measure>
    <time_frame>Baseline to 18 months</time_frame>
    <description>blood will be drawn and Total cholesterol will be measured using a Cholestech LDX point of care machine. Data will be reported as the change in total cholesterol over 18 months</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Diabetes Self Management Program only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>group education classes of the Diabetes Self-Management Program, (DSMP)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tailored Patient Navigation (PN) only</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>assisting patients in navigation to physician offices, allowing for standard of care to follow.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>DSMP AND Tailored Patient Navigation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Both group education classes and patient navigation</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Diabetes Self Management Program</intervention_name>
    <description>Diabetes Self Management Program (DSMP) in a group setting: The goal of this arm of the project is to try to get participants to engage in better diabetes self-care (blood glucose testing, medication taking, diet, exercise, stress reduction, etc.).
Groups randomized to one of two arms (DSMP only and CCN) will receive the DSMP. The DSMP has demonstrated significant improvements in communication with physicians, healthy eating, and hypoglycemia at six and twelve months. The DSMP and other self-management programs have been shown to increase self-efficacy, knowledge, and skill building; ensure accountability/monitoring; improve patient-provider interaction; leverage local assets; address sustainability, and be cost effective.</description>
    <arm_group_label>Diabetes Self Management Program only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Tailored Patient Navigation (PN) only</intervention_name>
    <description>Tailored Patient Navigation (PN) only: The goal of this arm of the project is to try to get participants to attend their recommended medical appointments. PN has been shown to improve health behavior and increase self-efficacy, all with low costs. We will have to add an additional eligibility criterion for this groupâ€”they have to be out of compliance with medical appointments. Most participants will need PN services, owing to missed, rescheduled, or infrequent appointments. This means not attending their office visits, as recommended, which typically is every 3 months. We will interact with them to verify attendance and, at times, to access patient medical records if needed.</description>
    <arm_group_label>Tailored Patient Navigation (PN) only</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>DSMP AND Tailored Patient Navigation</intervention_name>
    <description>DSMP AND Tailored Patient Navigation : Both group education classes and patient navigation</description>
    <arm_group_label>DSMP AND Tailored Patient Navigation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adults (age 18+);

          -  Appalachian residence, no plans to relocate out of the area in the next 18 months,

          -  Willingness and ability to participate (i.e., no major cognitive impairment)

          -  HbA1c levels at least 6.5%.

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nancy Schoenberg, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Kentucky</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Tiffany Scott</last_name>
    <phone>606 633 3339</phone>
    <email>Tiffany.scott@uky.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Kentucky</name>
      <address>
        <city>Lexington</city>
        <state>Kentucky</state>
        <zip>40536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nancy Schoenberg, PhD</last_name>
      <phone>859-323-8175</phone>
      <email>nesch@uky.edu</email>
    </contact>
    <contact_backup>
      <last_name>Tiffany Scott</last_name>
      <phone>859 323 5771</phone>
      <email>tiffany.scott@uky.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Nancy Schoenberg, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura Hieronymus, DNP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Cardarelli</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Brittany Smalls, PhD, MHSA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frances Feltner, DNP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Glen Mays</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Charnigo, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2017</study_first_submitted>
  <study_first_submitted_qc>March 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 23, 2018</study_first_posted>
  <last_update_submitted>March 15, 2018</last_update_submitted>
  <last_update_submitted_qc>March 15, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of Kentucky</investigator_affiliation>
    <investigator_full_name>Nancy Schoenberg</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

